Exhibitor profile

Molecular Targeting Technologies, Inc.

ExhibitorRadiopharma DeveloperFind them at SNMMI

Website to be confirmed.

Booth1758

Summary

About Molecular Targeting Technologies, Inc.

A Radiopharma Developer player with a presence on the SNMMI floor; commercial activity worth a closer look.

Longer summary placeholder. Replace once Bracken finalizes the exhibitor profile copy.

Recent activity

What we're seeing

BioPharma Reporter · 2026-06-11
Molecular Targeting Technologies Inc publishes dosimetry data at SNMMI 2026
The work builds on more than a decade of radiochemistry collaboration.
FierceBiotech · 2026-09-24
Molecular Targeting Technologies Inc closes Series C round to scale radiopharma manufacturing
The announcement comes amid tightening Mo-99 and Lu-177 supply.
Endpoints News · 2026-12-01
Molecular Targeting Technologies Inc partners with academic center on Actinium-225 program
Industry observers expect more activity of this kind in the run-up to SNMMI 2026.
Reuters Health · 2026-07-26
Molecular Targeting Technologies Inc files IND for next-generation PSMA-targeted agent
Coverage notes the company's growing footprint in the radioligand therapy space.
PR Newswire · 2026-10-07
Molecular Targeting Technologies Inc announces Phase II readout for lead theranostic candidate
Details remain limited but analysts read the move as a positioning play ahead of pivotal data.

Mocked while we wire the Exa integration. Headlines are illustrative.

Why they're at SNMMI

What we expect to see at the booth

Booth talking points, demos, and announcements to watch for. Bracken analyst note coming.

Bracken's take

A short Bracken POV will go here, drawing on our experience across this part of the radiopharma value chain. Specific commentary to be filled in by the team.

Editorial shown for exhibitors in Bracken's wheelhouse: radiopharma developers, isotope supply, CDMO/CMO, cyclotron, and imaging equipment.

Similar in this cluster

Companies you may also want to visit.

Booth1231

Actinium Pharmaceuticals

ExhibitorRadiopharma Developer

Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Actinium Pharmaceuticals.

View profile →

Booth2222

AtomVie Global Radiopharma Inc.

ExhibitorRadiopharma DeveloperCDMO / CMO

Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on AtomVie Global Radiopharma Inc..

View profile →

Booth2722

Bayer Oncology

ExhibitorRadiopharma Developer

Profile under construction. Check back closer to SNMMI 2026 for Bracken's read on Bayer Oncology.

View profile →